RRP9 promotes gemcitabine resistance in pancreatic cancer via activating AKT signaling pathway

BACKGROUND: Pancreatic cancer (PC) is a highly lethal malignancy regarding digestive system, which is the fourth leading factor of cancer-related mortalities in the globe. Prognosis is poor due to diagnosis at advanced disease stage, low rates of surgical resection, and resistance to traditional rad...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Zhiqi, Yu, Haitao, Yao, Wenyan, Zhu, Na, Miao, Ran, Liu, Zhiquan, Song, Xuwei, Xue, Chunhua, Cai, Cheng, Cheng, Ming, Lin, Ke, Qi, Dachuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9700947/
https://www.ncbi.nlm.nih.gov/pubmed/36434608
http://dx.doi.org/10.1186/s12964-022-00974-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9700947/
https://www.ncbi.nlm.nih.gov/pubmed/36434608
http://dx.doi.org/10.1186/s12964-022-00974-5

Ejemplares similares